SPDR Dow Jones Industrial Average ETF

SPDR S&P 500 ETF Trust

Invesco QQQ Trust Series 1

Novavax, Inc. Is a biotechnology company, which engages in the discovery, development, and commercialization of recombinant vaccines. The company was founded in 1987 and is headquartered in Gaithersburg, MD.

Novavax, Inc.

Novavax Inc

Novavax is trending after securing a non-exclusive licensing agreement with Pfizer for its Matrix-M adjuvant, a deal seen by many as a significant validation of its platform technology across potential new disease areas. The community is actively discussing the potential for upfront payments, substantial milestones, and royalties, while also looking for further partnerships, particularly for its advanced COVID-Flu combination vaccine. This recent strategic move, alongside the company's strengthened financial position, is generating optimism about future growth despite ongoing activist investor pressure.

Trump Media & Technology Group Corp. engages in operating social media and in the technology business. Its brands include TRUTH Social, TMTG+ and TMTG News. The company was founded on March 28, 2024 and is headquartered in Sarasota, FL.

Trump Media & Technology Group Corp.

Trump Media (DJT) is trending as discussions erupt over former President Trump's threats of new tariffs on European nations, stemming from their stance on Greenland and his apparent frustrations regarding the Nobel Peace Prize. This has ignited heated debate among the community, with many expressing concern over potential market instability and strained international relations, while supporters view these actions as beneficial for "America First" economic policies.

SSgA Active Trust - SPDR S&P 500 ETF Trust

The SPDR S&P 500 ETF Trust is seeing heightened volatility as President Trump's escalating tariff threats against NATO allies, particularly concerning Greenland, spark widespread geopolitical uncertainty. Community sentiment is sharply divided, with some anticipating a deeper market correction while others view the current downturn as a 'buy the dip' opportunity amidst global bond market concerns and a notable rise in precious metal prices. Investors are closely monitoring a potential Supreme Court ruling on tariffs as a key market mover.

Capricor Therapeutics, Inc. is a clinical-stage biotechnology company, which focuses on the development of transformative cell and exosome-based therapeutics for treating Duchenne muscular dystrophy (“DMD”), a rare form of muscular dystrophy which results in muscle degeneration and premature death, and other diseases with unmet medical needs. Its product candidate consists of CAP-1002, Engineered Exosomes, CAP-2003, and Exosome-Based Vaccine. The company was founded on June 17, 1996 and is headquartered in San Diego, CA.

Capricor Therapeutics Inc

Capricor Therapeutics is trending as the community closely follows its ongoing interactions with the FDA regarding the Biologics License Application for its Duchenne muscular dystrophy treatment, deramiocel, and the forthcoming submission of the full HOPE-3 clinical study report. Sentiment is divided, with many expressing strong bullishness and anticipating significant upside potential, while others voice concerns over perceived delays and discuss potential market manipulation, as analysts reiterate positive ratings for the company.

Corvus Pharmaceuticals, Inc. engages in the development of immune modulator product candidates with the potential to treat solid cancers, T-cell lymphomas, autoimmune diseases, and infectious diseases. Its product pipeline includes B Cell Activator and Anti-CD73, Adenosine Production Inhibitor Anti-CD73, ITK Inhibitor, A2AR Inhibitor, Anti-CXCR2, and A2BR Inhibitor. The company was founded by Richard A. Miller, Peter A. Thompson, Joseph J. Buggy, and Erik Verner on January 27, 2014 and is headquartered in South San Francisco, CA.

Corvus Pharmaceuticals Inc

Corvus Pharmaceuticals is trending due to highly positive Phase 1 clinical trial results for its drug, soquelitinib, in treating moderate to severe atopic dermatitis. This early data, especially in patients resistant to other treatments, is fueling community excitement about its potential as a significant new option in a large market, with discussions also revolving around the possibility of strategic partnerships or a buyout, alongside concerns about the drug's early development stage.

BlackRock Institutional Trust Company N.A. - iShares 20+ Year Treasury Bond ETF

iShares 20+ Year Treasury Bond ETF

TLT is experiencing significant volatility amid escalating geopolitical tensions, notably the US asserting control over Venezuela's oil and ongoing debates surrounding US tariffs, fueling a "flight to quality" narrative for some. The community is actively discussing whether these events, alongside large institutional bond purchases, will continue to boost Treasuries as a safe haven or intensify concerns over US debt and the Federal Reserve's independence.

ImmunityBio, Inc. is a clinical stage immunotherapy company. It develops next generation therapies that drive immunogenic mechanisms for defeating cancers and infectious diseases. The company's immunotherapy platform activates both the innate and adaptive immune systems to create long term immunological memory. ImmunityBio was founded by Patrick Soon-Shiong in 2014 and is headquartered in San Diego, CA.

ImmunityBio Inc

ImmunityBio (IBRX) is trending due to regulatory clarity for ANKTIVA's resubmission for papillary bladder cancer, requiring no new clinical trials, coupled with expanding international approvals. The community is actively discussing the potential for a significant short squeeze, driven by high short interest and exceptional volume, as many investors embrace the long-term "cancer cure" narrative. This optimism persists even as the broader market faces headwinds, highlighting IBRX's standout performance and promising pipeline.

AppLovin Corp. engages in the development and operation of a mobile marketing platform. It offers AppDiscovery, MAX, Adjust, and SparkLabs. Its software-based platform caters to mobile application developers to improve the marketing and monetization of applications. The company was founded by Andrew Karam, John Krystynak, and Adam Foroughi in 2011 and is headquartered in Palo Alto, CA.

Applovin Corp - Ordinary Shares - Class A

Applovin Corp

Applovin is experiencing significant volatility and trending discussions following a critical report alleging financial misconduct, compounded by broader weakness in the tech sector. While many in the community are dismissing the report as rehashed FUD and market manipulation, bulls are highlighting the company's strong AI-powered ad platform and anticipated robust Q4 earnings. This has fueled a sharp debate between those buying the dip and bears reacting to the serious claims, driving notable price swings.

ProShares Trust - ProShares Ultra Bloomberg Natural Gas 2x Shares

ProShares Ultra Bloomberg Natural Gas

BOIL is currently experiencing a significant surge, fueled by an intense Arctic air invasion across the United States that is driving up natural gas demand and futures prices. The strong upward momentum has triggered a notable short squeeze, with the community actively discussing substantial profits and anticipating continued upside as extreme cold weather is projected to persist. This volatility is characteristic of the 2x leveraged ETF, attracting both profit-takers and those eyeing further gains.

Top Wealth Group Holding Ltd. operates as a holding company, which provides caviar and caviar-based gourmet products. It focuses on supplying sturgeon caviar to customers under its own brand, Imperial Cristal Caviar. The company was founded by Kim Kwan Kings Wong on February 1, 2023 and is headquartered in Hong Kong.

Top Wealth Group Holding Ltd. - Ordinary Shares - Class A

Top Wealth Group Holding Ltd.

Top Wealth Group Holding Ltd. is currently trending due to news of a strategic acquisition and a recent public offering that sparked extreme volatility. The community is sharply divided between anticipating massive upside driven by its low float and projected profitability, and expressing caution over its significant price swings. Traders are actively debating if this presents a compelling buying opportunity or a cautionary tale, drawing parallels to other high-momentum low-float stocks.

statis crypto Watchlist

Bitcoin

Ethereum

Solana

Ripple

Dogecoin

Cardano

statis IN Watchlist

Nifty 50

Nifty Bank

Reliance Industries Ltd.

Zomato Ltd.

Tata Consultancy Services

Tata Motors Ltd.

HDFC Bank Ltd.

ITC Ltd.

Adani Enterprises Ltd

Axis Bank Ltd

Bajaj Finance Ltd

statis US Watchlist

SPDR S&P 500 ETF

Apple Inc.

Tesla Inc

Microsoft Corporation

NVIDIA Corp

 Hey, I want to invite you to join Stocktwits. It’s the largest global community of active traders. You’ll get access to the real-time market insights, news, discussion and much more! You can sign up using my unique link below 
 


 has invited you to join Stocktwits

<ul class="summary-bullets"><li>The airline operator stated that its fourth-quarter (Q4) revenue growth was affected by the government shutdown.&nbsp;</li><li>Delta projects 2026 earnings per share growth of 20% YoY to between $6.50 and $7.50.&nbsp;</li><li>Delta sees first-quarter 2026 total revenue growth of 5-7% and earnings per share between $0.50 and $0.90.</li></ul>Delta Air Lines (DAL) stock tumbled over 6% on Tuesday after a&nbsp;disappointing 2026 profit guidance that overshadowed a slight beat in its fourth-quarter earnings.The airline operator also stated that its fourth-quarter (Q4) revenue growth was affected by the government shutdown as&nbsp;the U.S. aviation regulator ordered a 10% reduction in air traffic to reduce pressure and ensure safety.<h2 class="st-heading-2">Financial Performance And Outlook</h2>In the fourth-quarter, Delta recorded $16.0 billion in operating revenue and earnings per share (EPS) of $1.86. Both revenue and EPS exceeded the analysts’ consensus estimate of $15.7 billion and $1.71, respectively, according to Fiscal AI data.&nbsp;The company said Q4 revenue grew 1.2% year-over-year (YoY) despite a temporary government shutdown impacting domestic operations. Delta projected a 2026 earnings per share growth of 20% YoY to between $6.50 and $7.50.&nbsp;Delta sees first-quarter 2026 total revenue growth of 5-7% and earnings per share between $0.50 and $0.90."2026 is off to a strong start with top-line growth accelerating on consumer and corporate demand. For the full year, we expect to deliver margin expansion and earnings growth of 20 percent year-over-year."-Ed Bastian, CEO, Delta Air Lines<h2 class="st-heading-2">Fleet Expansion&nbsp;</h2>Additionally, Delta announced that it has reached an agreement with Boeing (BA) to acquire 30 787-10 widebody aircraft, with options for an additional 30 planes.Deliveries are expected to start in 2031. The new aircraft promises improved fuel efficiency, cost advantages, and extended long-haul capabilities.&nbsp;"Delta is building the fleet for the future, enhancing the customer experience, driving operational improvements and providing steady replacements for less efficient, older aircraft in the decade to come," added Ed Bastian.&nbsp;Commenting on the deal, CNBC’s Jim Cramer said in a&nbsp;<a class="st-link-external" target="_blank" rel="noopener noreferrer nofollow" href="https://x.com/jimcramer/status/2011039345009140019">post</a> on X that Delta’s large aircraft order represents a major win with high profit potential.<figure class="image"><img src="https://news.stocktwits-cdn.com/Screenshot_2026_01_13_072344_png_7883f7e022.webp" alt="Screenshot 2026-01-13 072344.png" width="595" height="227"></figure><h2 class="st-heading-2">What’s The Retail Mood On Stocktwits?</h2>On Stocktwits, retail sentiment around&nbsp;<a href="https://stocktwits.com/symbol/DAL">Delta stock</a> changed to ‘extremely bullish’ from ‘bullish’ territory the previous day. Message volume also shifted to ‘extremely high’ from ‘high’ levels in 24 hours.&nbsp;<figure class="image"><img src="https://news.stocktwits-cdn.com/Screenshot_2026_01_13_073843_png_6882a4eb3e.webp" alt="DAL’s Sentiment Meter and Message Volume as of 07:40 a.m. ET on Jan. 13, 2026 | Source: Stocktwits" width="932" height="99"><figcaption>DAL’s Sentiment Meter and Message Volume as of 07:40 a.m. ET on Jan. 13, 2026 | Source: Stocktwits</figcaption></figure>DAL stock has gained over 9% in the last 12 months.&nbsp;Also See:&nbsp;<a href="https://stocktwits.com/news-articles/markets/equity/what-is-driving-intel-latest-rally-a-fresh-bull-case-from-key-banc/cmUX5XvR44F">What’s Driving Intel’s Latest Rally? A Fresh Bull Case From KeyBanc</a>For updates and corrections, email newsroom[at]stocktwits[dot]com.

A Delta Airlines plane sits on the tarmac at the Austin-Bergstrom International Airport.

Delta Air Lines Stock Tumbles Despite Q4 Earnings Beat – Even A Boeing Order Failed To Lift Confidence 

In the fourth-quarter, Delta recorded $16.0 billion in operating revenue and earnings per share (EPS) of $1.86, both exceeding analysts’ consensus estimates. 

DAL Stock Tumbles Pre-Market Despite Q4 Beat, Boeing Order: What Spooked Investors?

Equity

In the fourth-quarter, Delta recorded $16.0 billion in operating revenue and earnings per share (EPS) of $1.86, both exceeding analysts’ consensus estimates. 


Current Price	$36.47
Prev Close	$36.79
Open	$36.26
Dividend Yield	N/A
50-Day Moving Average	$35.33
Beta	N/A
Avg. Volume	9,540.27
PE Ratio	N/A

52-Week High	$37.11
52-Week Low	$24.10
Market Capitalization	N/A
EPS (Annual)	N/A
Price to Book	N/A
Revenue Per Employee	N/A
Enterprise Value/EBITDA	N/A

DVLU
First Trust Exchange-Traded Fund VI - First Trust Dorsey Wright Momentum & Value ETF

Feed

News

Sentiment

Fundamentals

Info

Latest DVLU News

DVLUFirst Trust Exchange-Traded Fund VI - First Trust Dorsey Wright Momentum & Value ETF